A brand new drug is vastly efficient at defending folks from HIV an infection and must be injected solely twice a 12 months.
WHO
Gilead Sciences, GSK, ViiV Healthcare
WHEN
1 to three years
In June 2024, outcomes from a trial of a brand new drugs to stop HIV have been introduced—they usually have been jaw-dropping. Lenacapavir, a remedy injected as soon as each six months, protected over 5,000 women and girls in Uganda and South Africa from getting HIV. And it was 100% efficient.
The drug, which is produced by Gilead, has different benefits. We’ve had efficient pre-exposure prophylactic (PrEP) medicine for HIV since 2012, however these have to be taken both day by day or upfront of every time an individual is uncovered to the virus. That’s a giant ask for wholesome folks. And since these medicines additionally deal with infections, there’s stigma hooked up to taking them. For some, the medicine are costly or laborious to entry. Within the lenacapavir trial, researchers discovered that injections of the brand new drug have been simpler than a day by day PrEP tablet, in all probability as a result of individuals didn’t handle to take the drugs day by day.
In 2021, the US Meals and Drug Administration accredited one other long-acting injectable drug that protects in opposition to HIV. That drug, cabotegravir, is manufactured by ViiV Healthcare (which is basically owned by GSK) and must be injected each two months. However regardless of enormous demand, rollout has been gradual.
Discover the complete 2025 listing of 10 Breakthrough Applied sciences.
Scientists and activists hope that the story will likely be completely different for lenacapavir. To date, the FDA has accredited the drug just for individuals who have already got HIV that’s proof against different therapies. However Gilead has signed licensing agreements with producers to provide generic variations for HIV prevention in 120 low-income international locations.
In October, Gilead introduced extra trial outcomes for lenacapavir, discovering it 96% efficient at stopping HIV an infection in simply over 3,200 cisgender homosexual, bisexual, and different males, in addition to transgender males, transgender girls, and nonbinary individuals who have intercourse with folks assigned male at delivery.
The United Nations has set a aim of ending AIDS by 2030. It’s formidable, to say the least: We nonetheless see over 1 million new HIV infections globally yearly. However we now have the medicines to get us there. What we’d like is entry.
